8-K
Current Report
Niagen Bioscience, Inc. Filed Acc 0001415889-16-006111
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading cdxc8k_june22016.htm…